Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia to VSV-induced oncolysis

被引：0
|
作者：
Tumilasci, Vanessa F. [1 ,3 ]
Oliere, Stephanie [1 ,3 ]
Bell, John [2 ]
Hiscott, John [1 ,3 ]
机构：
[1] McGill Univ, Mol Oncol Grp, Lady Davis Inst, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada
[2] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Ottawa, ON, Canada
来源：
CYTOKINE | 2008年 / 43卷 / 03期
关键词：
D O I：
10.1016/j.cyto.2008.07.262
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：287 / 287
页数：1
相关论文
共 50 条
  • [31] Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs
    Starczewska, Eliza
    Beyaert, Maxime
    Michaux, Lucienne
    Vekemans, Marie-Christiane
    Saussoy, Pascale
    Bol, Vanesa
    Echarri, Ainhoa Arana
    Smal, Caroline
    Van den Neste, Eric
    Bontemps, Francoise
    ONCOTARGET, 2016, 7 (25) : 38367 - 38379
  • [32] Rituximab-induced apoptosis in chronic lymphocytic leukemia cells is enhanced by Bcl-2 antisense oligonucleotides
    不详
    CLINICAL LYMPHOMA, 2002, 3 (03): : 142 - 143
  • [33] Venetoclax, the First BCL-2 Inhibitor for Use in Patients With Chronic Lymphocytic Leukemia
    Seymour, John
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 440 - 443
  • [34] BIMODAL BCL-2 EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA: INTERCLONAL AND INTRACLONAL HETEROGENEITY
    Degheidy, Heba A.
    Gadalla, Shahinaz
    Farooqui, Mohammed Z. H.
    Abbasi, Fatima
    Bauer, Steven
    Wiestner, Adrian
    Stetler-Stevenson, M. A.
    Gerald, Marti
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2011, 80B (06) : 379 - 380
  • [35] Bcl-2 antisense (Genasense) as monotherpay for refractory chronic lymphocytic leukemia.
    O'Brien, S
    Giles, F
    Rai, K
    Andreeff, N
    Cunningham, C
    Frankel, S
    Keating, M
    BLOOD, 2001, 98 (11) : 772A - 772A
  • [36] THE ROLE OF BCL-2 IN THE PATHOGENESIS OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA
    SCHENA, M
    GOTTARDI, D
    GHIA, P
    LARSSON, LG
    CARLSSON, M
    NILSSON, K
    CALIGARISCAPPIO, F
    LEUKEMIA & LYMPHOMA, 1993, 11 (3-4) : 173 - 179
  • [37] Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies
    Fevzi F. Yalniz
    William G. Wierda
    Drugs, 2019, 79 : 1287 - 1304
  • [38] Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies
    Yalniz, Fevzi F.
    Wierda, William G.
    DRUGS, 2019, 79 (12) : 1287 - 1304
  • [39] Bcl-2 expression levels in chronic lymphocytic leukemia: Correlation with other prognostic indicators
    Sargent, RL
    Craig, FE
    Swerdlow, SH
    MODERN PATHOLOGY, 2006, 19 : 245A - 245A
  • [40] Bcl-2 expression levels in chronic lymphocytic leukemia: Correlation with other prognostic indicators
    Sargent, RL
    Craig, FE
    Swerdlow, SH
    LABORATORY INVESTIGATION, 2006, 86 : 245A - 245A
12345